埃及代谢功能障碍相关的脂肪性肝病:流行病学,风险因素和管理挑战
Walaa Abdelhamed1, Mona Amin2, Imam Waked3
1Department of Endemic Medicine, Sohag University, Sohag 14322, Egypt.
World journal of gastroenterology
|December 11, 2025
概括
与代谢功能障碍相关的脂肪性肝病 (MASLD) 在埃及因生活方式因素和先前感染而越来越令人担忧. 有限的认识,诊断和治疗机会阻碍了对这种沉默的流行病的有效管理.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 公共卫生 公共卫生
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个重要的全球健康问题,埃及在中东和北非地区面临着高负担.
- 由于肥胖率上升,2型糖尿病,久坐不动的生活方式,饮食变化以及埃及以前的C型肝炎病毒感染,患病率加剧.
研究的目的:
- 审查埃及MASLD的流行病学,病理生理学,诊断挑战和治疗差距.
- 突出当地因素对MASLD在埃及日益增长的公共卫生重要性的影响.
主要方法:
- 对埃及MASLD现有文献的叙事综述.
- 对流行病学数据,风险因素,诊断局限性和治疗可及性的分析.
主要成果:
- 公众和医疗保健提供者对MASLD的认识有限.
- 诊断工具主要是传统的超声波,对先进的成像技术的访问受到限制.
- 治疗坚持程度较低;由于成本和系统问题,药物和手术选择往往无法获得.
结论:
- 在埃及,MASLD构成了严重的,未被认可的威胁,需要紧急的公共卫生干预.
- 有效的控制需要国家指导方针,综合护理,改进的诊断,可获得的治疗方法和加强提供者教育.
- 有针对性的策略至关重要,以防止MASLD成为埃及下一个沉默的肝病流行病.
相关概念视频
Overview of Lipid Metabolism
4.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.7K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
159
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
159
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
200
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
200
Liver Physiology
3.4K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.4K
Chronic Pancreatitis II: Collaborative Care
286
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
286


